Earnings Alerts

Globe Life (GL) Earnings: Robust 3Q Operating EPS Surpasses Estimates at $3.49

By October 24, 2024 No Comments
  • Globe Life’s operating EPS for Q3 was $3.49, surpassing the estimated $3.06.
  • The adjusted book value per share came in at $83.92 compared to the forecast of $84.94.
  • The company’s book value per share was reported at $54.65, below the anticipated $59.92.
  • Total revenue met expectations at $1.46 billion.
  • Life insurance premium revenue amounted to $818.6 million, slightly under the estimated $824.9 million.
  • Health insurance premium revenue was $354.0 million, marginally higher than the expected $353.6 million.
  • Insurance underwriting income significantly exceeded forecasts with $387.4 million against an estimate of $342.3 million.
  • Net investment income was close to predictions at $285.0 million, with a slight shortfall from the projected $285.4 million.
  • Projected net operating income per share for the year ending December 31, 2025, is expected to range between $13.20 and $13.90.
  • Analyst recommendations include 7 buys and 5 holds, with no sell ratings.

Globe Life on Smartkarma

Analysts at Baptista Research on Smartkarma have published two insightful reports on Globe Life Inc. The first report, titled “Globe Life Inc.: A Bear’s Perspective! – Major Drivers,” highlights the company’s impressive second-quarter performance in 2024. Globe Life reported a net income of $258 million, showing a 20% growth from the previous year. The net operating income also saw a significant increase to $271 million, reflecting a 14% rise and indicating improved profitability and operational efficiency.

The second report, “Globe Life Inc.: Initiation of Coverage – Strategic Review and Exit from Proposed Acquisitions due to Financial Prudence! – Major Drivers,” focuses on the significant financial improvements Globe Life reported in the first quarter. The company’s net income rose notably to $254 million, showcasing a robust performance across various segments. Analysts pointed out a 10% year-over-year increase in net operating income to $264 million, signaling strong operational performances driving the company’s financial strength.


A look at Globe Life Smart Scores

FactorScoreMagnitude
Value3
Dividend2
Growth4
Resilience3
Momentum5
OVERALL SMART SCORE3.4

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Globe Life shows promising long-term prospects. With strong scores in Growth and Momentum, the company is positioned for expansion and market success. The high Momentum score reflects positive investor sentiment and the potential for continued upward movement in the company’s stock price. Additionally, Globe Life’s Growth score indicates the company’s ability to increase revenue and expand its market presence.

In terms of value and resilience, Globe Life is rated moderately, suggesting a stable financial foundation and reasonable valuation. However, the lower score in Dividend indicates that the company may not be a top choice for income-seeking investors. Overall, Globe Life’s strategic position in the insurance industry, particularly in Texas, combined with its solid performance across key Smartkarma indicators, paints a favorable picture for its long-term outlook.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Analytics and News
  • ✓ Events & Webinars